Avalo Therapeutics, Inc. Annual Selling and Marketing Expense in USD from 2015 to 2021

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Avalo Therapeutics, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2015 to 2021.
  • Avalo Therapeutics, Inc. Selling and Marketing Expense for the quarter ending June 30, 2022 was $2.8M, a 250% increase year-over-year.
  • Avalo Therapeutics, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2022 was $6.29M, a 180% increase year-over-year.
  • Avalo Therapeutics, Inc. annual Selling and Marketing Expense for 2021 was $2.83M, a 20.7% increase from 2020.
  • Avalo Therapeutics, Inc. annual Selling and Marketing Expense for 2020 was $2.34M, a 57.7% increase from 2019.
  • Avalo Therapeutics, Inc. annual Selling and Marketing Expense for 2019 was $1.48M, a 172% increase from 2018.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $2.83M +$485K +20.7% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-02
2020 $2.34M +$857K +57.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $1.48M +$939K +172% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-08
2018 $545K -$24.6K -4.32% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 $570K +$570K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.